Alpha Tau Medical Ltd. (DRTS)
NCM · Healthcare · Biotechnology
$9.85
+1.76%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$889.7M
Shares Outstanding
90.3M
Exchange
NCM
Currency
USD
About Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -9.6M | -10.7M | -12.6M | -13.3M |
| Net Income | -10.1M | -11.7M | -12.1M | -22.9M |
| Diluted EPS | $nan | $nan | $nan | $-0.26 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -32.1M | -35.7M | -36.0M | -42.3M |
| Net Income | -33.8M | -29.2M | -31.8M | -42.6M |
| Diluted EPS | $-0.53 | $-0.42 | $-0.45 | $nan |